TVTX   $17.95  -0.83% Market Closed After Close 17.97 0.11%

Travere Therapeutics Inc
Total Cash 325.40M
totalCashPerShare 4.254
EBITDA -275.06M
Total Debt 403.23M
quickRatio 2.908
currentRatio 3.043
Total Revenue 177.64M
debtToEquity 2662.085
Revenue/Share 2.311
ROA -0.30702
ROE -5.82605
grossProfits
freeCashflow -224.35M
operatingCashflow -288.86M
earningsGrowth
revenueGrowth 0.681
grossMargins -0.31445
ebitdaMargins -1.54838
operatingMargins -1.23902
profitMargins -0.82135004
enterpriseValue 1.44B
forwardPE -13.923078
floatShares 56.31M
sharesOutstanding 76.49M
sharesShort 6.96M
sharesShortPriorMonth 9.25M
dateShortInterest
sharesPercentSharesOut 0.09%
heldPercentInsiders 0.01%
heldPercentInstitutions 1.17%
Short Ratio help_outline 2.90%
shortPercentOfFloat 0.10%
impliedSharesOutstanding
bookValue 0.198
Price To Book help_outline 91.41
earningsQuarterlyGrowth
netIncomeToCommon -383.45M
trailingEps -4.98%
forwardEps -1.30%
enterpriseToEbitda -5.25
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.66 3Q 2024
institutionsCount 241
lastUpdated Oct. 22, 2024, 12:24 a.m.